Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 65 (3), 336-41

Mesenchymal Stem Cell: An Efficient Mass Producer of Exosomes for Drug Delivery

Affiliations
Review

Mesenchymal Stem Cell: An Efficient Mass Producer of Exosomes for Drug Delivery

Ronne Wee Yeh Yeo et al. Adv Drug Deliv Rev.

Abstract

Advances in biomedical research have generated an unprecedented number of potential targets for therapeutic intervention to treat disease or delay disease progression. Unfortunately, many of these targets are not druggable as they are intracellular, present in many cell types, poorly soluble or rapidly inactivated. Although synthetic drug vehicles have successfully circumvented many of these problems, natural particulates such as exosomes that intrinsically possess many attributes of a drug delivery vehicle are highly attractive as potentially better alternatives. Of the cell types known to produce exosomes, the readily available proliferative, immunosuppressive and clinically tested human mesenchymal stem cell (MSC) is the most prolific producer. Its exosomes are therapeutic in animal model of disease and exhibit immunosuppressive activity. The quality and quantity of exosome production is not compromised by immortalization to create a permanent MSC cell line. Therefore, MSC is well suited for mass production of exosomes that are ideal for drug delivery.

Similar articles

See all similar articles

Cited by 149 PubMed Central articles

See all "Cited by" articles

LinkOut - more resources

Feedback